Persistent disabling breathlessness in chronic obstructive pulmonary disease.
about
The need for greater opioid pharmacovigilance in COPDFactors influencing pharmacological treatment in COPD: a comparison of 2005 and 2014.Support needs of patients with COPD: a systematic literature search and narrative review.Effect of Inhaled Nebulized Furosemide (40 and 120 mg) on Breathlessness during Exercise in the Presence of External Thoracic Restriction in Healthy Men.
P2860
Persistent disabling breathlessness in chronic obstructive pulmonary disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Persistent disabling breathlessness in chronic obstructive pulmonary disease.
@en
Persistent disabling breathlessness in chronic obstructive pulmonary disease.
@nl
type
label
Persistent disabling breathlessness in chronic obstructive pulmonary disease.
@en
Persistent disabling breathlessness in chronic obstructive pulmonary disease.
@nl
prefLabel
Persistent disabling breathlessness in chronic obstructive pulmonary disease.
@en
Persistent disabling breathlessness in chronic obstructive pulmonary disease.
@nl
P2860
P356
P1476
Persistent disabling breathlessness in chronic obstructive pulmonary disease.
@en
P2093
Josefin Sundh
Magnus Ekström
P2860
P304
P356
10.2147/COPD.S119992
P407
P577
2016-11-09T00:00:00Z